Thierry Voet, PhD, graduated with a Master in bioscience engineering: cell and gene biotechnology from the University of Leuven (KU Leuven, Belgium), and holds an inter-university post-graduate in human genetics. Following his PhD at KU Leuven, he pioneered single-cell microarray analyses, and in 2010, he joined the Cancer Genome Project at the Wellcome Sanger Institute (Sanger, UK) to explore next-generation sequencing technologies for single-cell genomics. Since 2011, he has been an associate faculty member at Sanger, and a founding member of the Sanger-EBI Single-Cell Genomics Centre. In 2014, he became associate professor at KU Leuven following a five-year tenure track, and was appointed full professor in 2017. His research focuses on (1) the development of methods for single-cell multiomics, and (2) their application to study the biology of cellular heterogeneity in development, aging, and disease.
COORDINATING LEAD PI
Thierry Voet, PhD
KU Leuven
Thierry Voet, PhD, graduated with a Master in bioscience engineering: cell and gene biotechnology from the University of Leuven (KU Leuven, Belgium), and holds an inter-university post-graduate in human genetics. Following his PhD at KU Leuven, he pioneered single-cell microarray analyses, and in 2010, he joined the Cancer Genome Project at the Wellcome Sanger Institute (Sanger, UK) to explore next-generation sequencing technologies for single-cell genomics. Since 2011, he has been an associate faculty member at Sanger, and a founding member of the Sanger-EBI Single-Cell Genomics Centre. In 2014, he became associate professor at KU Leuven following a five-year tenure track, and was appointed full professor in 2017. His research focuses on (1) the development of methods for single-cell multiomics, and (2) their application to study the biology of cellular heterogeneity in development, aging, and disease.
